does ambetter cover glp-1 for weight loss How to access with insurance GLP-1 Medications for Weight Loss:

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

The current FDA-approved option [Rybelsus] has more restrictions around timing of medication with food and other medications, says Dr

Participation in BALANCE is voluntary for manufacturers, state Medicaid agencies, and Part D plans

Oct 5;14(4):45365

(KFFs report says 12 states and not 13 because it was released before North Carolina began covering the drugs for obesity.) The report notes that South Carolina plans to add coverage for obesity at the end of 2024, and Connecticut has a legislative mandate to add coverage but it has not yet been implemented